The packaging of double-stranded genomic DNA into some viral and all bacteriophage capsids is driven by powerful molecular motors. In bacteriophage T4, the motor consists of the portal protein assembly composed of twelve copies of gene product 20 (gp20, 61 kDa) and an oligomeric terminase complex composed of gp16 (18 kDa) and gp17 (70 kDa). The packaging motor drives the 171-kbp T4 DNA into the capsid utilizing the free energy of ATP hydrolysis. Evidence suggests that gp17 is the key component of the motor; it exhibits ATPase, nuclease, and in vitro DNA-packaging activities. The N-and C-terminal halves of gp17 were expressed and purified to homogeneity and found to have ATPase and nuclease activities, respectively. The N-terminal domain exhibited 2-3-fold higher K cat values for gp16-stimulated ATPase than the full-length gp17. Neither of the domains, individually or together, exhibited in vitro DNApackaging activity, suggesting that communication between the domains is essential for DNA packaging. The domains, in particular the C-terminal domain or a mixture of both the N-and C-terminal domains, inhibited in vitro DNA packaging that is catalyzed by full-length gp17. In conjunction with genetic evidence, these data suggest that the domains compete with the full-length gp17 for binding sites on the portal protein. A model for the assembly of the T4 DNA-packaging machine is presented.
The packaging of double-stranded DNA into viral procapsids requires energy to translocate and compact the long negatively charged nucleic acid (1) . As packaging proceeds, an internal pressure builds up that must be opposed by progressively more force to encapsidate the genome. Bacteriophage T4 requires a 56-m-long double-stranded DNA molecule to be condensed into a preformed 120-nm-long prolate capsid during the last 10 min of the 25-min life cycle (2, 3) . In the case of the homologous phage 29, the packaging motor generates ϳ50 piconewtons, nearly 20 times more than that required by myosin for moving an actin filament (4) , which makes the DNA-packaging motors among the strongest biological machines.
Two of the gene products (gp) 1 of bacteriophage T4, gp16 (18 kDa) and gp17 (70 kDa), form the "terminase" 2 complex, although the stoichiometry of these proteins in the complex is unknown (5) (6) (7) . In the T4-packaging pathway (parts of which as presented here are hypothetical), the terminase recognizes the concatameric viral DNA, cuts it to generate the first end that is to enter the capsid, and links it to the empty prohead by placing the end into the empty channel of the portal protein (gp20) situated at a unique vertex of the capsid. By analogy with the 29 and T3 bacteriophages, which package DNA at a rate of 2 bp/one ATP hydrolysis (8, 9) , ϳ10 5 molecules of ATP would be consumed for packaging one molecule of T4 DNA. When no further DNA can be packaged into the T4 capsid, the gp17 terminase makes a second cut in the DNA. The terminase and the unpackaged DNA then dissociate from the filled head and reassociate with another empty prohead (7) .
On its own, gp17 exhibits weak ATPase and nuclease activities (10, 11) . However, in the presence of gp16, the ATPase activity is increased Ͼ50-fold (10, 12) , and the packaging efficiency is enhanced 50 -100-fold (5, 10, 13) . The gp16 exhibits none of these activities. The N-terminal half of gp17 consists of an essential ATPase catalytic center; it contains Walker A, Walker B, and catalytic carboxylate motifs that are characteristic of enzymes having ATPase activity (14) (see Fig. 1 ). The conserved catalytic residues in these motifs are critically required for gp16-stimulated ATPase and DNA-packaging activities (15, 16) . Secondary structure analyses predict that these residues are part of a core of ␤-strands that presumably form the nucleotide binding fold found in the ATP binding pockets of ATPases (15, 17) . The C-terminal half of gp17 has a catalytic metal binding motif consisting of critical Asp, Glu, and His residues, similar to that seen in nucleases and phosphodiesterases (18, 19 ) (see Fig. 1 ). Mutations in these residues resulted in a loss of gp17-nuclease activity but not the ATPase activity. Sequence comparisons and functional analyses show that the basic features and organization are generally well conserved among terminases of other tailed phages as well as herpes viruses (14, 20) .
Here we report that the ATPase and nuclease activities of gp17 are separated into the N-and C-terminal domains and that their functions are regulated through conformational transitions during the packaging process. The gp16-stimulated ATPase activity of the N-terminal domain is 2-3-fold greater than that of the full-length gp17, suggesting that this domain * The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ Both authors contributed equally to and share first authorship for this work. encodes all of the interaction sites and functional motifs required for gp17-ATPase stimulation. Although neither domain exhibited in vitro DNA-packaging activity, the C-domain, or a mixture of both domains, strongly inhibited the in vitro DNApackaging activity of the full-length gp17. These results led us to postulate a model for the assembly of the phage T4 DNApackaging machine.
EXPERIMENTAL PROCEDURES
Bacteria-Escherichia coli P301 (sup Ϫ ) was used as the nonsuppressor strain for in vitro DNA-packaging experiments and B40 (su ϩ1 ) as the amber suppressor strain for preparing phage stocks. E. coli BL21 (sup Ϫ ) strain was used for maintaining the pET-15b plasmids carrying g17 recombinants. E. coli BL21(DE3) and BL21(DE3) pLys-S (Novagen) were used as host strains for expression.
Bacteriophage-Wild-type T4, 17Q425am, 17K166am, and 17H436am were constructed previously in this laboratory (15) .
Recombinant Constructions-The phage T7 expression vector pET15b (amp r ) (21) was used for construction of all of the recombinants reported in this study. The DNA corresponding to the g17 sequence was amplified by PCR. A common 5Ј forward primer, 5Ј-CGCGGGATCCG-ATGGAACAACCGATTAATGTATTAAATG-3Ј (nt 1-28) was used for the construction of the gp17-K577 (gp17, aa 1-577), N343 (gp17, aa 1-343), and N360 (gp17, aa 1-360) constructs. The corresponding reverse primers used were: K577 3Ј reverse primer, 5Ј-CGCGGGATCC-TTATTTTGAAAATACTTCAGATGCTAATCGCAT-3Ј(nt 1731-1701); N343 3Ј reverse primer, 5Ј-CGCGGGATCCTTAAGAACCATTAATGG-TTTGTATGCTCCA-3Ј (nt 1029 -1002); and N360 3Ј reverse primer, 5Ј-CGCGGGATCCTTAAGAAGTCCCTTCAAACGCTGCAGTATGT-T-3Ј (nt 1080 -1051). Primers used for the construction of the C343 (gp17, aa 343-577) and C360 (gp17, aa 360 -577) domains are as follows: the C343 5Ј forward primer, 5Ј-CGCGGGATCCGTCTTCATTA-GCTCAATTCCGTCAAGAAC-3Ј (nt 1029 -1057) and the C360, 5Ј forward primer, 5Ј-CGCGGGATCCGTCTGGTACATTAATTTCAGGA-ATGAAATTAG-3Ј (nt 1080 -1111). The same 3Ј reverse primer shown above for K577 was also used for construction of the C343 and C360 domains, as both are truncated at K577. Note that the nucleotide numbers in parentheses correspond to the coding sequence of gp17; italicized nucleotides represent the tag sequence added to the 5Ј-end for efficient cutting at the adjacent BamHI sequence shown in bold).
The g17 DNA fragments were amplified by PCR using purified phage T4 DNA as a template. The Precision-Taq DNA polymerase (Stratagene) was used for amplifications to minimize the introduction of any nonspecific mutations during PCR. The amplified DNA was purified by agarose gel electrophoresis, and the appropriate DNA band was sliced out and the DNA extracted using the Qiagen gel extraction protocol. The purified DNA was then inserted into the BamHI site of pET-15b by ligating the BamHI-treated mutant DNA with the BamHI-treated dephosphorylated pET-15b DNA. The ligated DNA was transformed into E. coli XL10 Gold cells (Stratagene) and mini-prep plasmid DNAs were prepared by the alkaline lysis procedure. The DNAs were then tested for orientation by BglII digestion and sequenced to confirm the in-frame insertion at the BamHI site of the vector and absence of any nonspecific mutation in the cloned insert. Appropriate recombinants were transformed into BL21(DE3) pLys-S cells for protein expression.
Purification of gp17 Proteins-The domain clones were induced with IPTG at 30°C for 2 h to overexpress the His-tagged gp17-K577, -N360 and -C360 domains. Each protein was purified by the common procedure described as follows. All operations were conducted at 4°C. The induced E. coli were harvested by centrifugation at 3000 ϫ g for 10 min, and the cell pellets were resuspended in 50 mM Tris-HCl buffer, pH 8.0, and 5 mM imidazole. The cells were then lysed by sonication (Branson Sonifier 250), and the cell-free extracts were centrifuged at 28,000 ϫ g for 30 min. The supernatant was loaded onto a pre-equilibrated 5-ml His-Trap (Amersham Biosciences) column. The His-tagged protein was eluted with a 5-250 mM imidazole gradient. EDTA was added to each collected fraction to a final concentration of 5 mM. The peak fractions were pooled and applied to a 5-ml HiTrap Q-Sepharose high performance (Amersham Biosciences) column, which was pre-equilibrated with 50 mM Tris-HCl buffer, pH 8.0, and 5 mM MgCl 2 , and the bound protein was eluted with a 0 -1 M NaCl gradient in the same buffer. The eluted protein was concentrated by an UltaraFree 4 centrifugal filter (50 kDa normal molecular mass limit, Millipore). Limited Proteolysis-Purified gp17-K577 (65 l, 0.5 mg/ml) was mixed with trypsin (final concentration 10 g/ml) or 1-chloro-3-tosylamido-7-amino-2-heptanone-chymotrypsin (final concentration 10 g/ ml) in 50 mM Tris-HCl buffer, pH 8.5, 0.2 M NaCl, 1 mM CaCl 2 , and 0.5 mM ATP. Reaction mixtures were incubated at 25°C for 5-120 min. Reactions were stopped by adding 6ϫ SDS sample buffer (35 mM TrisHCl buffer, pH 6.8, 30% glycerol, 10% SDS, 9.3% dithiothreitol, and 0.012% bromphenol blue). The samples were separated by electrophoresis on SDS-PAG (13%) and stained with Coomassie Blue R-250.
For N-terminal amino acid sequencing, the protein bands were transferred to a polyvinylidene difluoride membrane. The membrane was stained with Coomassie Blue R-250, and the 41-and 26-kDa bands were sliced out and subjected to N-terminal Edman sequencing using a Procise 492 (Applied Biosystems) protein sequencer at the Protein Separation and Analysis Laboratory, Purdue University.
ATPase Assays-ATPase assays were performed according to Leffers and Rao (10) . The purified proteins (1-3 M), either alone or with gp16 (10 -30 M), were incubated in a reaction mixture (20 l) containing 0.05-2 mM cold ATP and 5 Ci of [␥-
32 P]ATP (specific activity 3000 Ci/mmol) at 37°C in ATPase buffer (50 mM Tris-HCl, pH 7.5, 0.1 M NaCl and 5 mM MgCl 2 ) for 20 min. The reactions were terminated by adding EDTA to a final concentration of 50 mM followed by thin layer chromatography and autoradiography. Quantification of data was done by phosphorimaging (Storm 820, Molecular Dynamics). To obtain kinetic data, the concentration of cold ATP was varied (0.05-2 mM), and the concentration of [␥-32 P]ATP was fixed at 75 nM. The data shown (Table  I) were an average of duplicates or triplicates from two independent experiments. From the 32 P i value, total [P i ] produced was calculated, and the K m values were determined from Lineweaver-Burk plots using the Enzyme Kinetics Module and SigmaPlot 8.0 software.
Transformation Assay-Equivalent amounts of the miniprep plasmid DNAs of g17 recombinants, which had been isolated from the nonexpression strain E. coli BL21, were transformed into E. coli BL21 or E. coli BL21(DE3). BL21(DE3) as opposed to BL21 is an expression strain and produces significant amounts of T7 RNA polymerase in the absence of IPTG (21) . This in turn produces high basal levels of gp17. Colonies were counted, phenotypes of constructs in BL21(DE3) were recorded in comparison with the same in BL21 (GT, glassy and transparent; RH, round and healthy), and the BL21(DE3)/BL21 ratio of the colonies was obtained for every construct (22) .
DNA Cleavage Assay-Streak-purified cultures of E. coli BL21(DE3) pLys-S cells containing cloned g17 constructs were grown at 30°C to 4 ϫ 10 8 cells/ml in Moore/ampicillin/chloramphenicol medium for pET15b plasmids or Moore/kanamycin/chloramphenicol medium for pET-9d plasmids, and IPTG was added to a final concentration of 1 mM (22) . Moore medium consists of tryptone (2%), yeast extract (1.5%), dextrose (0.2%), NaCl (0.8%), Na 2 HPO 4 (0.2%), and KH 2 PO 4 (0.1%). Expression of the construct was induced by IPTG (1 mM). One-ml aliquots were withdrawn immediately prior to induction and at 60 and 120 min after induction. Each aliquot was centrifuged at 3000 ϫ g for 5 min, and the pellet was used to isolate the plasmid DNA. Ten l of plasmid DNA were electrophoresed on a 0.8% (w/v) agarose gel. Terminase 2 -defective constructs show no cleavage of plasmid DNA. Terminase-proficient constructs cleave plasmid and E. coli genomic DNAs and generate a characteristic smear that extends throughout the lane during electrophoresis (22, 23) .
In Vitro DNA-packaging Assays-In vitro DNA-packaging assays were performed using purified proteins and 16am17amrII extracts according to the procedure of Leffers and Rao (10) .
RESULTS
Limited Proteolysis-The gp17 constructs used for the experiments reported here contained 26 additional amino acids (aa) at the N terminus as a result of the in-frame fusion to the T7 expression vector pET-15b. These extra residues included a hexahistidine tag and an arginine at the 17th position (Fig. 1) . The C-terminal 33 aa of gp17 are highly susceptible to nonspecific proteolysis during purification (10, 13) . These were removed by introducing a termination codon at aa 578 of gp17 to produce gp17-K577. Like the full-length gp17, this truncated protein, which also includes the 26 additional N-terminal residues, exhibited gp16-stimulated ATPase (K cat of 77 versus 103 for the full-length gp17), in vitro DNA-packaging, and in vivo DNA-cleavage activities (16) .
Based on the sequence analyses and functional characteriza-tion of mutants, the putative N-terminal ATPase domain must extend at least up to the ATPase-coupling Motif III (aa residues 285-287) (14 -16) . No other essential ATPase motif or aa residues have yet been identified beyond this sequence. The start of the putative C-terminal nuclease domain must precede the Asp 401 residue, because this residue is the first critical residue of the catalytic metal binding motif that is required for terminase activity (18) .
We predict that a linker region that connects the putative N-terminal and C-terminal domains resides between residues 287 and 401. This linker is likely to be flexible and sensitive to limited proteolysis. Limited proteolysis of gp17-K577 with trypsin and chymotrypsin showed two major proteolytic-resistant products with molecular masses of 41 kDa and 26 kDa, respectively (trypsin digestion results are shown in Fig. 2 ). The N-terminal sequence of the 41-kDa tryptic fragment was found to be Ser-His-Met-Leu-Glu, which occurs after Arg 17 in the N-terminal His-tag region (Fig. 1) . The 26-kDa fragment had an N-terminal sequence of Gln-Glu-His-Thr-Ala-Ala, which corresponds to aa 350 -355 of gp17 immediately following Arg 349 . These data are consistent with the predicted flexible linker region and the sequence and functional data summarized in Fig. 1 (14 -16, 18) .
Design and Expression of Putative ATPase and Nuclease Domain Constructs-Secondary structure predictions show that Arg 349 is in the middle of a conserved ␣-helix between aa 345 and 356 (Fig. 3) . Therefore, disruption of this helix might interfere with folding and function. Thus, the small side-chain residues Ser 343 and Ser 360 in the flanking loops were chosen as possible termini for constructing the domain fragments. Four gp17 domain constructs, aa 1-343 and 1-360 containing the N-terminal ATPase site, as well as aa 343-577 and 360 -577 containing the C-terminal nuclease site, were engineered into the T7 vector pET15b for overexpression in E. coli (Fig. 1) . The constructs produced the corresponding polypeptides up to 5-10% of the total cell protein (Fig. 4a) . Of these, the 1-360 (N360) and 360 -577 (C360) proteins exhibited greater solubility (as determined by low-speed centrifugation of cell-free extracts and comparing the relative amounts of the protein in the supernatant and pellet). Both of these proteins were purified to apparent homogeneity as judged by the presence of a single band upon SDS-PAGE (Fig. 4b) .
gp16-stimulated ATPase-All of the constructs exhibited a weak basal ATPase activity. Only the N360 domain and gp17-K577, but not the C360 domain, exhibited the gp16-stimulated ATPase activity (Fig. 5) . The K m , K cat , and gp16:gp17 ratio for ATPase activity of the N360 domain were similar to those of gp17-K577 and full-length gp17 (Table I ). The catalytic capacity (K cat ) of N360 was, however, 2-3 times greater than that of the full-length gp17. Mixing of the N360 and C360 domains did not have a significant effect on the N360 ATPase activity.
Terminase Activity-Terminase activity was analyzed by the in vivo transformation assay and the in vivo DNA cleavage assay. When g17 constructs were transformed into E. coli BL21(DE3), which produced a high basal level of gp17, the active terminase constructs cleaved the resident plasmid DNA as well as the E. coli genomic DNA, resulting in the formation of GT (sick) colonies; on the other hand, the inactive terminase constructs produced RH (normal) colonies (16, 18) . Analysis of the plasmid DNA by agarose gel electrophoresis showed a characteristic cleaved DNA smear with active terminase constructs, whereas the inactive terminase constructs showed sharp plasmid DNA bands (16, 18) .
The N360 domain exhibited the RH phenotype and no DNA cleavage activity (Fig. 6) . The C360 domain showed the GT
FIG. 2. Limited trypsin proteolysis of gp17-K577. SDS-PAGE (13%)
showing the limited proteolysis of gp17-K577 after treatment with trypsin. The numbers at the top correspond to the time points after treatment with trypsin (see "Experimental Procedures" for details).
FIG. 1. gp17 recombinants and their features.
The recombinants were constructed as described under "Experimental Procedures." The Arg residues shown correspond to the trypsin cleavage points as determined by N-terminal aa sequencing of the products. The ATPase and nuclease motifs were defined by earlier studies (14 -16, 18 phenotype and produced a DNA smear after IPTG induction. The DNA cleavage activity by the C360 domain was comparable with that of gp17-K577. DNA Packaging-Neither the N360 nor C360 domain was able to package DNA in vitro (Table II) , nor were the separated domains together able to package DNA. In quantitative terms, the packaging activity in the domains, if any, is Ͻ5 orders of magnitude of that of gp17-K577. Each domain independently inhibited the gp17-K577 in vitro DNA-packaging activity. The C-domain exhibited a stronger inhibitory activity than the Ndomain, whereas the two domains together synergistically inhibited DNA packaging by 87-fold (Table II) . DISCUSSION Terminases are multifunctional ATPases that are required for directional translocation of viral genomes through a 30 -40-Å diameter portal channel into a capsid shell (3). Elucidation of their precise roles in the mechanisms of ATP energy transduction and DNA packaging requires the characterization of functional sites present in the terminase polypeptide chain.
Limited proteolysis data strongly suggest that the phage T4 gp17 terminase consists of two functional domains. The puri- FIG. 3 . Multiple sequence alignment and secondary structure predictions of the linker region between N-terminal ATPase and C-terminal terminase domains. ClustalW (www.ebi.ac.uk/clustalw/) and JPRED (www.compbio.dundee.ac.uk/ϳwww-jpred/) were used for sequence alignment and secondary structure predictions, respectively, for seven T4 family gp17s (GenBank TM accession numbers: T4, P17312; RB69, NP_861869; RB49, AAF23757; 44RR2.8t, NP_932508; Aeh1, NP_944105; KVP40, NP_899601; KVP20, BAB96804). SS1 and SS2 are the predicted secondary structures of the linker region of T4 gp17 (green) and all seven T4 family gp17s combined (red), respectively; con represents consensus sequence. The residue Arg 349 , the trypsin cleavage point, is shown in red. The residues Ser 343 and Ser 360 shown in blue were chosen as the termini for the construction of N-and C-terminal domains.
FIG. 4. Overexpression and purification of terminase domains.
All of the recombinants were overexpressed under the genetic background of E. coli BL21(DE3) pLys-S. See Fig. 1 and "Experimental Procedures" for details on the recombinant constructions. Cultures were grown to 4 ϫ 10 8 cells/ml at 30°C and induced with 1 mM IPTG. Aliquots of culture were withdrawn at 0, 60, and 120 min and electrophoresed on a 12% SDS-PAG. The proteins were stained with Coomassie Blue R-250. a, overexpression of recombinant proteins. Arrows correspond to the new protein bands that are overexpressed following IPTG induction. The numbers at the top of the lanes correspond to the minutes after IPTG addition. The molecular mass of each band corresponded to that predicted by the cloned DNA fragment. b, SDS-PAGE (4 -20% gradient gel) showing the purified recombinant proteins. The proteins were purified as described under "Experimental Procedures." A purified full-length gp17 was also electrophoresed in the same gel for size comparison. fied N-and C-terminal halves of gp17 showed ATPase and terminase activities, respectively, that are comparable with the corresponding activities in the full-length protein. These data established the presence of two separate structural domains connected by an external and flexible linker region, with each domain exhibiting the respective function independently. Neither of the domains, either alone or together, showed any in vitro DNA-packaging activity. Thus, communication between the domains must be maintained to orchestrate the ATPase and nuclease functions during the packaging process. For instance, the terminase activity must be activated for packaging initiation, suppressed during active DNA translocation, and reactivated after head filling. Previous mutational analyses showed that subtle substitutions in the catalytic residues, some of which merely changed the chain-length by a single C-C bond (1.54 Å), resulted in a complete loss of ATPase or terminase activity (e.g. ATPase-defective mutants K166R, D255E, and E256D; nuclease-defective mutant D401N) (see Fig. 1) (15,  16, 18) . Movement of the terminase structural domains through conformational switching could position the key residues in appropriate catalytic context, thereby regulating the ATPase and nuclease activities during DNA packaging.
A model for the assembly of the phage T4 DNA-packaging machine is proposed (Fig. 7) , which explains the functional behavior of the isolated domains. It is well documented (10, 13) that gp16 exists as an oligomer or as a dimeric oligomer (scanning transmission electron microscope data in Ref. 13 gave a value of 8.11 Ϯ 2.68 subunits/oligomer), whereas gp17 exists predominantly as a monomer (10) . However, the presence of a small fraction of gp17 as dimers, trimers, and so on, was observed by native PAGE (10) . The gp17-K577, N360, and C360 proteins eluted as monomers in gel permeation chromatography. Thus gp17, unlike gp16, does not form stable oligomers on its own and is inactive (or poorly active) in the monomeric form, because only a weak ATPase activity is observed with the purified gp17.
The gp16 oligomer interacts with gp17 and facilitates the formation of a holoterminase complex. A conformational change ensues following gp16-gp17 interaction, converting an inactive gp17 monomer into an active oligomeric gp17-ATPase motor (Fig. 7) . Because maximal stimulation of ATPase activity was observed at a gp16:gp17 ratio of ϳ8:1 (Table I) (10, 12) , we suggest that the stoichiometry of the terminase complex is one gp17 subunit to one gp16 oligomer. gp16 apparently acts as a conformational switch, allowing the formation of an active gp17 oligomer through reversible interactions with gp17 (Fig. 7,  steps A-C) . Several lines of evidence support this scheme. Specific stimulation of gp17-ATPase by gp16 should, minimally, require gp16-gp17 interactions. The formation of a highly active gp17 oligomer (K cat Х 400) following incubation with gp16 (12) , but lacking the gp16 subunits in the oligomer, suggests that the gp16-gp17 interactions are reversible; in fact, all of the available evidence point to an unstable interaction between gp16 and gp17 (5, 12, 24) . The depiction of the gp17 oligomer as a pentamer is, however, purely speculative, and experiments are underway to determine the stoichiometry of subunits in the gp17 oligomer.
The gp16-gp17 interaction sites for the formation of the active gp17 oligomer likely reside in the N-domain, because the N-domain retains full gp16-stimulated ATPase activity. However, when the N-domain is added along with gp17-K577, the N-domain inhibits the gp17-K577-dependent in vitro DNA packaging, because its incorporation into the oligomerization process (Fig. 7, steps A, B , and E) results in the formation of nonproductive complexes (Fig. 7, NPC) , which are not competent for packaging DNA.
The C-domain of gp17 interacts with the portal protein gp20 resulting in the assembly of a functional DNA-packaging machine (Fig. 7, step D) . This assembly can also occur in the absence of gp16 (Fig. 7, step E) , although less efficiently. It is well established that gp16 stimulates in vitro DNA packaging FIG. 6 . Only the C-domain exhibited the terminase activity. The recombinant constructs in the genetic background of E. coli BL21(DE3) pLys-S were grown to 4 ϫ 10 8 cells/ml at 30°C and induced with 1 mM IPTG. Aliquots of cultures were collected at 0, 60, and 120 min following induction, and miniprep plasmid DNAs were prepared by the alkaline lysis procedure and electrophoresed on a 0.8% (w/v) agarose gel. Smeared appearance of DNA indicates terminase activity. Table on top of the figure shows the phenotypes of the colonies obtained in transformation assay (see "Experimental Procedures"). RH (round and healthy) represents no terminase activity and GT (glassy and transparent) represents positive terminase activity.
TABLE II
In vitro DNA packaging activity of N360 and C360 domains Purified gp17-K577 (1.25 g) and N360 and C360 domains (10 g each) were used for in vitro DNA packaging activity. For analyzing inhibition by the domains, protein concentrations were used in accordance with footnotes a, b, and c to the table. In vitro DNA packaging assays were performed using 16am17amrII extracts and 1-2 g of purified wild-type phage T4 DNA according to the procedure described by Leffers and Rao (10) . pfu, plaque-forming units. b K577 (1.25 g) was used along with 10 g of N360 or C360. c K577 (1.25 g) was used along with 5 g of N360 ϩ 5 g of C360.
only when gp17 concentration in the reaction mixture is low (5, 10, 13) ; in the standard in vitro packaging reactions that contain high gp17 concentrations, the presence of gp16 is unnecessary (Table II) (10) . Strong inhibition of in vitro DNA packaging by the C-domain suggests that the C-domain competes with K577 for portal interaction sites. Previous genetic evidence supports this suggestion. A cold-sensitive mutation in the portal protein gp20 is suppressed by a second site mutation in the C-terminal region of gp17 (25) . A conserved sequence containing acidic and hydrophobic residues ( 560 IDYADKDD 567 ) was identified in the C terminus of gp17 as being a potential portal interaction site (14) (see Fig. 1 ). A similar sequence in the C terminus of phage ( 636 LSGEDE 641 ) and T3 ( 571 LYWEDD 576 ) terminases has been shown to be a portal recognition site (26, 27) . The suggested C-domain-portal interaction however does not exclude a possible interaction between the N-domain and the portal protein. Genetic and sequence analyses predicted a second portal interaction site, 322 LYNDEDIFDD 331 , which is localized in the "linker" region of the N-domain (13, 14) .
The model predicts that the N-and C-domains together would interfere with both the formation of an active gp17 oligomer as well as its assembly with the portal vertex. Virtually all of the steps in the assembly model, as well as the necessary interaction of the assembly intermediates with the DNA (not shown in Fig. 7) , would be inhibited when both of the domains are present. The synergistic inhibition of in vitro DNA packaging in the presence of both the N-and C-domains is therefore consistent with this reasoning.
This study has established the presence of separate ATPase and nuclease structural domains in phage T4 terminase. It provided insights on the interaction sites and the dynamic assembly of a functional DNA-packaging machine in phage T4. Previous biochemical and genetic data had shown that the bacteriophage terminase may have a similar separation of functions into structural domains, although there is no significant overall sequence similarity between the two terminases (28, 29) ) and a C-terminal cos-cleaving nuclease site with functional motifs, such as leucine zipper and helicase-ATPase, have been characterized (14, 28 -30) . Such a functional separation was also inferred from the alignments of similarly conserved functional motifs of numerous terminases from double-stranded DNA bacteriophages and herpes viruses (14, 31) . Thus, the functional domains observed in phage T4 terminase may represent a common theme among phage and viral terminases. The availability of functionally competent isolated terminase domains from phage T4 should help the investigation of their structures and elucidate their mechanism of ATPase hydrolysis and nuclease activity, as well as the process of ATPase-dependent DNA packaging into phage heads.
